Disruption of glycogen synthase kinase-3-beta activity leads to abnormalities in physiological measures in mice

Behavioural Brain Research

Volumn 221, Issue 1, 2011, Pages 246-252

  Ahnaou, A ^a   Drinkenburg, W H I M ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Body temperature and activity; Circadian rhythms; Glycogen synthase kinase 3 beta; Mice; Sleep; Telemetry

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA;

ALERTNESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORE TEMPERATURE; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; LIGHT DARK CYCLE; LOCOMOTION; MOUSE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; PROTEIN EXPRESSION; REM SLEEP; SLEEP TIME; SLEEP WAKING CYCLE; TELEMETRY; TIME; TRANSGENIC MOUSE;

ANIMALS; BODY TEMPERATURE; BRAIN; CIRCADIAN RHYTHM; ELECTROENCEPHALOGRAPHY; GLYCOGEN SYNTHASE KINASE 3; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; PHOTOPERIOD; POLYSOMNOGRAPHY; SLEEP; TELEMETRY;

EID: 79954634100     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.03.004     Document Type: Article

References (47)

1. Abe M., Herzog E.D., Block G.D. Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. Neuroreport 2000, 11:3261-3264.
2. Barbini B., Bertelli S., Colombo C., Smeraldi E. Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res 1996, 65:121-125.
3. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005, 122:261-273.
4. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., et al. Lithium antagonizes dopamine-dependent behaviors mediated by an Akt/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 2004, 101:5099-5104.
5. Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. J Biol Chem 2006, 281:32072-32080.
6. Beaulieu J.M., Zhang X., Rodriguiz R.M., Sotnikova T.D., Cools M.J., Wetsel W.C., et al. Role of GSK3β in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 2008, 105:1333-1338.
7. Benington J.H., Heller H.C. Restoration of brain energy in metabolism as the function of sleep. Prog Neurobiol 1995, 55:347-360.
8. Campbell S.S., Gillin J.C., Kripke D.F., Janowsky D.S., Risch S.C. Lithium delays circadian phase of temperature and REM sleep in a bipolar depressive: a case report. Psychiatry Res 1989, 27:23-29.
9. Costall B., Eniojukan J.F., Naylor R.J. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour. Eur J Pharmacol 1983, 96:201-210.
10. D'Aquila P.S., Peana A.T., Carboni V., Serra G. Different effect of desipramine on locomotor activity in quinpirole-treated rats after repeated restraint and chronic mild stress. J Psychopharmacol 2000, 14:347-352.
11. Dzirasa K., Ribeiro S., Costa R., Santos L.M., Lin S.C., Grosmark A., et al. Dopaminergic control of sleep-wake states. J Neurosci 2006, 26:10577-10589.
12. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001, 359:1-16.
13. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612.
14. Gould T.D., Manji H.K. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 2005, 30:1223-1237.
15. Gould T.D., Manji H.K. The Wnt signaling pathway in bipolar disorder. Prog Clin Neurosci 2002, 8:497-511.
16. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase-3β in cellular signalling. Prog Neurobiol 2001, 65:391-426.
17. Hallonquist J.D., Goldberg M.A., Brandes J.S. Affective disorders and circadian rhythms. Can J Psychiatry 1986, 31:259-272.
18. Harvey A.G. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 2008, 165:820-829.
19. Harvey A.G., Mullin B.C., Hinshaw S.P. Sleep and circadian rhythms in children and adolescents with bipolar disorder. Dev Psychopathol 2006, 18:1147-2116.
20. Harwood A.J. Neurodevelopment and mood stabilizers. Curr Mol Med 2003, 3:282-472.
21. Hoit B.D., Kiatchoosakun S., Restivo J., Kirkpatrick D., Olszens K., Shao H., et al. Naturally occurring variation in cardiovascular traits among inbred mouse strains. Genomics 2002, 79:679-685.
22. Jope R.S., Bijur G.N. Mood stabilizers, glycogen synthase kinase-3β and cell survival. Mol Psychiatry 2002, 7:S35-S45.
23. Jones S.H., Hare D.J., Evershed K. Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder. Bipolar Disord 2005, 7:176-186.
24. Judd L.L. Effect of lithium on mood, cognition, and personality function in normal subjects. Arch Gen Psychiatry 1979, 36:860-866.
25. Kaladchibachi S.A., Doble B., Anthopoulos N., Woodgett J.R., Manoukian AS Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. J Circadian Rhythms 2007, 5:3.
26. Kong J., Shepel P.N., Holden C.P., Mackiewicz M., Pack A.I., Geiger J.D. Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep. J Neurosci 2002, 22:5581-5587.
27. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996, 93:8455-8459.
28. Knowles J.B., Cairns J., MacLean A.W., Delva N., Prowse A., Waldron J., et al. The sleep of remitted bipolar depressives: comparison with sex- and age-matched controls. Can J Psychiatry 1986, 31:295-298.
29. Kozak W., Conn C.A., Kluger M. Body temperature, motor activity, and feeding behavior of mice treated with β-chlornaltrexamine. Physiol Behav 1995, 58:353-362.
30. Kume K., Kume S., Park S.K., Hirsh J., Jackson F.R. Dopamine is a regulator of arousal in the fruit fly. J Neurosci 2005, 25:7377-7384.
31. Léna I., Parrot S., Deschaux O., Muffat-Joly S., Sauvinet V., Renaud B., et al. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep-wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J Neurosci Res 2005, 81:891-899.
32. Lenox R.H., Gould T.D., Manji H.K. Endophenotypes in bipolar disorder. Am J Med Genet 2002, 114:391-406.
33. Leroy k, Brion J.P. Developmental expression and localization of glycogen synthase kinase-3β in rat brain. J Chem Neuroanat 1999, 16:279-293.
34. LeSauter J., Silver R. Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. Biol Psychiatry 1993, 34:75-83.
35. Manji H.K., Lenox R.H. The nature of bipolar disorder. J Clin Psychiatry 2000, 61:42-57.
36. Pandi-Perumal S.R., Moscovitch A., Srinivasan V., Spence D.W., Cardinali D.P., Brown G.M. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine. Prog Neurobiol 2009, 88:264-271.
37. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 1997, Academic Press, San Diego, CA. 2nd ed.
38. Porzgen P., Park S.K., Hirsh J., Sonders M.S., Amara SG The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. Mol Pharmacol 2001, 59:83-95.
39. Plante D.T., Winkelman J.W. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry 2008, 165:830-843.
40. Prickaerts J., Moechars D., Cryns K., Lenarts I., Van Craenendonck H., Goris I., et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 2006, 30:9022-9029.
41. Roybal K., Theobold D., Graham A., DiNieri J.A., Russo S.J., Krishnan V., et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007, 104:6406-6411.
42. Ryves W.J., Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 2001, 280:720-725.
43. Sitaram N., Nurnberger J.I., Gershon E.S., Gillin J.C. Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder. Am J Psychiatry 1982, 139:571-576.
44. Seggie J., Werstiuk E.S., Grota L. Effect of chronic lithium treatment on twenty four hour variation in plasma and red blood cell lithium and sodium concentrations, drinking behavior, body weight, kidney weight, and corticosterone levels. Prog Neuropsychopharmacol Biol Psychiatry. 1982, 6:455-458.
45. Spittales K., Van den Haute C., Van Dorpe J., Geerts H. Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axon pathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem 2000, 275:41340-41349.
46. Spittales K., Van den Haute C., Van Dorpe J., Terwel D., Vandezande K. Neonatal neural overexpression of glycogen synthase kinase-3β reduces brain size in transgenic mice. Neuroscience 2002, 113:797-808.
47. Tilleman K., Stevens I., Spittaels K., Van Den Haute C., Clerens S., Van Den Bergh G., et al. Differential expression of brain proteins in glycogen synthase kinase-3β transgenic mice: a proteomics point of view. Proteomics 2002, 2:94-104.